Search results for "SPUTUM"

showing 10 items of 96 documents

The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients

2017

Altres ajuts: This work was supported by Fundació Catalana de Neumología (FUCAP) and Centro de Investigación Biomédica en Red de Enfermedades Respiratorias(CIBERES). CIBERES is an initiative of the Instituto de Salud Carlos III. The bronchial microbiome in chronic lung diseases presents an abnormal pattern, but its microbial composition and regional differences in severe asthma have not been sufficiently addressed. The aim of the study was to describe the bacterial community in bronchial mucosa and secretions of patients with severe chronic asthma chronically treated with corticosteroids in addition to usual care according to Global Initiative for Asthma. Bacterial community composition was…

DNA BacterialMale0301 basic medicineMicrobiology (medical)BiopsyMicrobial ConsortiaBronchimedicine.disease_causeImmunoglobulin EMicrobiology03 medical and health sciencesRNA Ribosomal 16SBronchoscopymedicinePrevotellaHumansMicrobiomeAsthmaMucous MembraneLungBacteriabiologyStreptococcusSputumFusobacteriaBiodiversitySequence Analysis DNAImmunoglobulin EMiddle Agedmedicine.diseasebiology.organism_classificationAsthmaCross-Sectional Studies030104 developmental biologymedicine.anatomical_structureImmunologybiology.proteinMetagenomeSputumFemaleMicrobiomemedicine.symptomBronchial aspirateResearch Article
researchProduct

Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa

2014

The bronchial microbiome in severe COPD during stability and exacerbation in patients chronically colonised by Pseudomonas aeruginosa (PA), has not been defined. Our objective was to determine the characteristics of the bronchial microbiome of severe COPD patients colonised and not colonised by P. aeruginosa and its changes during exacerbation. COPD patients with severe disease and frequent exacerbations were categorised according to chronic colonisation by P. aeruginosa. Sputum samples were obtained in stability and exacerbation, cultured, and analysed by 16S rRNA gene amplification and pyrosequencing. Sixteen patients were included, 5 of them showing chronic colonisation by P. aeruginosa.…

DNA BacterialMaleMicrobiology (medical)ExacerbationMolecular Sequence DataBronchiBiologymedicine.disease_causeDNA RibosomalArticleMicrobiologyCohort StudiesPulmonary Disease Chronic ObstructiveRNA Ribosomal 16SHaemophilusmedicineCluster AnalysisHumansMicrobiomeMoraxellaPhylogenyAgedAged 80 and overStreptococcusPseudomonas aeruginosaMicrobiotaSputumGeneral MedicineSequence Analysis DNAMiddle Agedbiology.organism_classificationrespiratory tract diseasesColonisationInfectious DiseasesSputumFemalemedicine.symptomEuropean Journal of Clinical Microbiology & Infectious Diseases
researchProduct

Analysis of microbiota in stable patients with chronic obstructive pulmonary disease

2014

To identify the bacterial diversity (microbiota) in expectorated sputum, a pyrosequencing method that investigates complex microbial communities of expectorated sputum was done in 19 stable chronic obstructive pulmonary disease patients (mean (SD) FEV1: 47 (18%) of predicted value). Using conventional culture, 3 phyla and 20 bacterial genera were identified, whereas the pyrosequencing approach detected 9 phyla and 43 genera (p < 0.001). In sputum the prevalent genera with pyrosequencing approach were Streptococcus, Actinomyces, Neisseria, Haemophilus, Rothia, Fusobacterium, Gemella, Granulicatella, Porphyromonas, Prevotella and Veillonella. Enterobacteriaceae, detected frequently in convent…

DNA BacterialMaleMicrobiology (medical)VeillonellaPolymerase Chain ReactionPathology and Forensic MedicineMicrobiologyPulmonary Disease Chronic ObstructiveRNA Ribosomal 16SHaemophilusPrevotellamedicineHumansImmunology and AllergyProspective StudiesMoraxellaAgedAged 80 and overBacteriabiologyMicrobiotaSputumGeneral MedicineMiddle Agedbiology.organism_classificationBacterial Typing TechniquesMolecular TypingRNA BacterialFusobacteriumGemellaImmunologyMetagenomeSputumFemalemedicine.symptomActinomycesAPMIS
researchProduct

Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD.

2014

Background In models of COPD, environmental stressors induce innate immune responses, inflammasome activation and inflammation. However, the interaction between these responses and their role in driving pulmonary inflammation in stable COPD is unknown. Objectives To investigate the activation of innate immunity and inflammasome pathways in the bronchial mucosa and bronchoalveolar lavage (BAL) of patients with stable COPD of different severity and control healthy smokers and non-smokers. Methods Innate immune mediators (interleukin (IL)-6, IL-7, IL-10, IL-27, IL-37, thymic stromal lymphopoietin (TSLP), interferon γ and their receptors, STAT1 and pSTAT1) and inflammasome components (NLRP3, NA…

EXPRESSIONMaleINTERLEUKIN-6InflammasomesCOPD PathologyChronic Obstructive Pulmonary DiseaseRespiratory SystemImmunity NLRP3 COPDBronchiReceptors Cell SurfaceRespiratory MucosaPULMONARYInterferon-gammaPulmonary Disease Chronic ObstructiveMARKERSThymic Stromal LymphopoietinSPUTUMNLR Family Pyrin Domain-Containing 3 ProteinCytokine Receptor gp130Humans1506HMGB1 ProteinAdaptor Proteins Signal TransducingAgedScience & TechnologyRECEPTORInterleukinsSmoking1103 Clinical SciencesMiddle AgedInterleukin-1 Receptor-Like 1 ProteinImmunity InnateInnate Immunityrespiratory tract diseasesANTIINFLAMMATORY CYTOKINESTAT1 Transcription FactorCase-Control StudiesT-CELLSASTHMACytokinesFemaleCOPD Pathology Innate ImmunityCarrier ProteinsLife Sciences & BiomedicineBronchoalveolar Lavage FluidSMOKERSThorax
researchProduct

Near-fatal asthma phenotype in the ENFUMOSA Cohort.

2007

Summary Background Near-fatal asthma (NFA) is characterized by severe asthma attacks usually requiring intensive care unit admission. This phenotype of asthma has been studied mainly in acute conditions. Methods The aim of our study was to compare the clinical, functional and inflammatory characteristics of NFA patients with mild to severe asthmatics in stable conditions. We recruited 155 asthmatic patients from five centres of the European Network for Understanding Mechanisms of Severe Asthma: 67 patients with mild-to-moderate asthma controlled by low/medium doses of inhaled corticosteroids; 64 with severe asthma that, despite treatment with high doses of inhaled corticosteroids, long-acti…

Hypersensitivity ImmediateMaleAllergyVital CapacityAnti-asthmatic AgentSeverity of Illness Indexlaw.inventionCohort StudiesLeukocyte CountlawRisk FactorsForced Expiratory Volumenear-fatal asthmaImmunology and AllergyMedicineAnti-Asthmatic AgentsMiddle AgedIntensive care unitInflammation near-fatal asthma severe asthma sputumPhenotypeFemalemedicine.symptomCohort studyAdultinflammation; near-fatal asthma; severe asthma; sputumsevere asthmamedicine.medical_specialtyPartial PressureImmunologyStatus AsthmaticusDrug Administration ScheduleInternal medicineSeverity of illnessHumansRisk factorGlucocorticoidsAsthmaSkin TestsInflammationbusiness.industrysputummedicine.diseaseAsthmarespiratory tract diseasesOxygeninflammationImmunologySputumPatient Compliancebusiness
researchProduct

Probable disseminated Mycobacterium abscessus subspecies bolletii infection in a patient with idiopathic CD4+ T lymphocytopenia: a case report.

2012

Abstract Introduction Rapidly growing mycobacteria are opportunistic pathogens in patients with underlying risk factors. Mycobacterium abscessus subsp. bolletii is a newly recognized member of rapidly growing mycobacteria, isolated from respiratory tract and cutaneous infections. Case presentation We describe a case of chronic disseminated infection caused by M. abscessus subsp. bolletii in a 38-year-old Sri Lankan man with idiopathic CD4+ T lymphocytopenia. Idiopathic CD4+ T lymphocytopenia is a rare cause of immunodysfunction that, similar to human immunodeficiency virus infection, causes a depletion of CD4+ T lymphocytes. M. abscessus subsp. bolletii infection was diagnosed by culture is…

ImipenemSettore MED/07 - Microbiologia E Microbiologia ClinicaDisseminated infectionlcsh:MedicineCase ReportMycobacterium abscessusMicrobiologyMycobacterium abscessus subsp. bolletii rapidly growing mycobacteriaClarithromycinMycobacterium bolletiiClarithromycinmedicineCefoxitinMedicine(all)biologybusiness.industryPatient affectedlcsh:RMycobacterium bolletiiGeneral MedicineMycobacterium bolletii; idiopathic CD4+ T lymphocytopeniabiology.organism_classificationbacterial infections and mycosesCD4+ T lymphocytopeniaImmunologyidiopathic CD4+ T lymphocytopeniaSputumbacteriaCD4+ T-Lymphocytopeniamedicine.symptom<it>Mycobacterium abscessus</it> subsp. <it>bolletii</it> rapidly growing mycobacteriabusinessmedicine.drug
researchProduct

Similar cellular composition of induced sputum in Marathon and Half-Marathon runners

2013

In our previous studies, we reported increased neutrophil (PMN) differential counts in induced sputum of marathon (M) runners (Bonsignore et al, 2001). Conversely, increased bronchial epithelial cell (BEC) differential counts were found in half-marathon (HM) runners (Chimenti et al, 2010). To better understand the differences previously found between M and HM runners, we studied 11 non-asthmatic amateur athletes (HM n=6, M n=5, age: 44.5±6.7 yrs, race time: HM 101±18 min, M 218±35 min) participating to the 2012 Palermo Marathon. We collected induced sputum samples 4 to 5 days before the race (PRE), 2 hours after the race (RACE), and the following morning (POST). Induced sputum was processed…

Induced sputum Marathon Half Marathon
researchProduct

Effect of chest physiotherapy on cystic fibrosis sputum nanostructure: an experimental and theoretical approach.

2022

AbstractCystic fibrosis (CF) is a disease characterized by the production of viscous mucoid secretions in multiple organs, particularly the airways. The pathological increase of proteins, mucin and biological polymers determines their arrangement into a three-dimensional polymeric network, affecting the whole mucus and impairing the muco-ciliary clearance which promotes inflammation and bacterial infection. Thus, to improve the efficacy of the drugs usually applied in CF therapy (e.g., mucolytics, anti-inflammatory and antibiotics), an in-depth understanding of the mucus nanostructure is of utmost importance. Drug diffusivity inside a gel-like system depends on the ratio between the diffusi…

Low field NMRCystic FibrosisSputumPharmaceutical ScienceNanostructuresMucusSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoCystic fibrosiMesh size distributionDrug deliveryHumansCystic fibrosis; Drug delivery; Low field NMR; Mesh size distribution; Rheology; SputumRheologyPhysical Therapy ModalitiesDrug delivery and translational research
researchProduct

Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients

2016

Background: Inhaled corticosteroid (ICS) with long-acting beta-2 agonists is a well-documented combination therapy for chronic obstructive pulmonary disease (COPD) based on its additive anti-inflammatory properties. By contrast, the recommendation of ICS in combination with long-acting muscarinic antagonist (LAMA) is not evidence-based. In this study, neutrophils obtained from COPD patients were used to compare the anti-inflammatory effects of aclidinium bromide (a long-acting muscarinic antagonist) with corticosteroids and their potential additive effect. Methods: Human sputum and blood neutrophils were isolated from healthy individuals ( n = 37), patients with stable COPD ( n = 52) and th…

Male0301 basic medicineNeutrophilsVesicular Acetylcholine Transport ProteinsAnti-Inflammatory AgentsDrug ResistanceNon-neuronal cholinergic systemPulmonary Disease Chronic Obstructive0302 clinical medicineMuscarinic acetylcholine receptorCOPDDrug SynergismAclidinium bromideMuscarinic acetylcholine receptor M2Middle AgedReceptors MuscarinicBronchodilator AgentsCorticosteroidDrug Therapy CombinationFemaleInflammation Mediatorsmedicine.drugPulmonary and Respiratory Medicinemedicine.medical_specialtyCombination therapymedicine.drug_classCorticosteroid resistanceMuscarinic AntagonistsFluticasone propionateCholine O-Acetyltransferase03 medical and health sciencesAclidinium bromideInternal medicinemedicineHumansCOPDAgedDose-Response Relationship Drugbusiness.industryResearchSputumMuscarinic antagonistmedicine.disease030104 developmental biologyEndocrinology030228 respiratory systemCase-Control StudiesFluticasonebusinessTropanesRespiratory Research
researchProduct

Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: A nested case-control study

2005

We evaluated the aberrant promoter methylation profile of a panel of 3 genes in DNA from tumor and sputum samples, in view of a complementary approach to spiral computed tomography (CT) for early diagnosis of lung cancer. The aberrant promoter methylation of RARbeta2, p16(INK4A) and RASSF1A genes was evaluated by methylation-specific PCR in tumor samples of 29 CT-detected lung cancer patients, of which 18 had tumor-sputum pairs available for the analysis, and in the sputum samples from 112 cancer-free heavy smokers enrolled in a spiral CT trial. In tumor samples from 29 spiral CT-detected patients, promoter hypermethylation was identified in 19/29 (65.5%) cases for RARbeta2, 12/29 (41.4%) f…

MaleCancer ResearchPathologymedicine.medical_specialtyLung NeoplasmsReceptors Retinoic AcidGastroenterologyInternal medicinemedicineHumansPromoter Regions GeneticLung cancerCyclin-Dependent Kinase Inhibitor p16Agedbusiness.industryTumor Suppressor ProteinsSmokingRespiratory diseaseSputumPromoterDNA NeoplasmMethylationDNA MethylationMiddle Agedmedicine.diseaseSpiral computed tomographyOncologyCase-Control StudiesDNA methylationNested case-control studySputumFemalemedicine.symptombusinessTomography Spiral ComputedInternational Journal of Cancer
researchProduct